TransCode Therapeutics Announces Withdrawal of Registration Statement
06.12.2022 - BOSTON, Dec. 06, 2022 (GLOBE NEWSWIRE) - TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (the “Company”), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that it withdrew the Registration ...
Alan Freidman Exchange Commission Company Annual Report On Form Transcode Therapeutics Inc About Transcode Note Regarding Forward Looking
Source: wallstreet-online.de